Dentin Sensitivity
Conditions
Interventions
This project is subdivided into four studies. The Orto1 and Perio1 studies are observational studies. The Orto2 and Perio2 studies are clinical researches. All interventions consist of topical applica
3 - Laser Group (LA) - 26 individuals in each trial - application of nitrocellulose varnish and low-power laser semiconductor diode GaAIAs and InGaAIP in the buccal cervical region in 3 points (1 mesi
4 - Bioglass Group (BV) - 26 individuals in each trial - application of experimental bioglass containing K and Sr in vehicle of nitrocellulose varnish and led light in the buccal cervical region in 3
Drug
Procedure/surgery
D003101
D008027
D010070
D005898
Sponsors
Universidade Estadual de Ponta Grossa
Universidade Estadual de Ponta Grossa
Eligibility
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: Orto1 study: patients older than 18 years; completed corrective orthodontic treatment; permanent dentition erupted prior to orthodontic treatment; agree to participate; good general health. Orto2 study: patients older than 18 years; completed corrective orthodontic treatment; permanent dentition erupted prior to orthodontic treatment; agree to participate; good general health; clinically diagnosed dentin hypersensitivity. Perio1 study: patients older than 18 years; completed non-surgical periodontal treatment; agree to participate; have good general health. Perio2 study: patients older than 18 years; completed non-surgical periodontal treatment; agree to participate; good general health; clinically diagnosed dentin hypersensitivity.
Exclusion criteria
Exclusion criteria: Orto1 study: in orthodontic retreatment; use of anti-inflammatory, analgesic and / or psychiatric medications (chronic or up to 72 hours prior to clinical evaluations); pregnant or lactating women; carious lesions; endodontic treatment; pulp and / or periapical lesion; in treatment for dentin hypersensitivity; who underwent periodontal surgery in the last 3 months; restored in the last 3 months; fixed or removable prosthetic abutments; with prosthetic crowns; extensively restored; restorations covering the cervical region and / or regions that interfere with the assessment of dentin hypersensitivity. Orto2 study: in orthodontic retreatment; use of anti-inflammatory, analgesic and / or psychiatric medications (chronic or up to 72 hours prior to clinical evaluations); pregnant or lactating women; carious lesions; endodontic treatment; pulp and / or periapical lesion; in treatment for dentin hypersensitivity; who underwent periodontal surgery in the last 3 months; restored in the last 3 months; fixed or removable prosthetic abutments; with prosthetic crowns; extensively restored; restorations covering the cervical region and / or regions that interfere with the assessment of dentine hypersensitivity; allergic to the components of the formulations that will be used. Period study1: use of anti-inflammatory, analgesic and / or psychiatric medications (chronic or up to 72 hours before clinical evaluations); pregnant or lactating women; carious lesions; endodontic treatment; pulp and / or periapical lesion; in treatment for dentin hypersensitivity; who underwent periodontal surgery in the last 3 months; restored in the last 3 months; fixed or removable prosthetic abutments; with prosthetic crowns; extensively restored; restorations covering the cervical region and / or regions that interfere with the assessment of dentin hypersensitivity. use of anti-inflammatory, analgesic and / or psychiatric medications (chronic or up to 72 hours prior to clinical evaluations); pregnant or lactating women; carious lesions; endodontic treatment; pulp and / or periapical lesion; in treatment for dentin hypersensitivity; who underwent periodontal surgery in the last 3 months; restored in the last 3 months; fixed or removable prosthetic abutments; with prosthetic crowns; extensively restored; restorations covering the cervical region and / or regions that interfere with the assessment of dentine hypersensitivity; allergic to the components of the formulations that will be used.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| EXPECTED OUTPUT 1. PRIMARY OUTPUT FOR ORTO 1 AND PERIO 1 STUDIES. It is expected to find high prevalence and severity of cervical dentin hypersensitivity (HSDC) in patients after different dental treatments (orthodontic and periodontal), through the HSDC analysis method by evaporative (air blast) and tactile (clinical probe) stimuli when using the NRS (Numerical Rating Scale) pain scale from 0 to 10 (where 0 corresponds to “no pain” and 10 corresponds to “worst pain imaginable”).;EXPECTED OUTPUT 2. PRIMARY OUTPUT FOR ORTO 2 AND PERIO 2 STUDIES. It is expected that HSDC values ??measured by the evaporative (air blast) and tactile (clinical probe) stimuli method using the NRS pain scale ( Numerical Rating Scale) from 0 to 10 (where 0 corresponds to “no pain” and 10 corresponds to “worst pain imaginable”), so that the experimental bioglass group might have similarity with the HSDC values measured for the groups that used laser and the groups that used potassium oxalate. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are not expected. | — |
Countries
Brazil
Contacts
Public ContactAna Dalmolin
Universidade Estadual de Ponta Grossa
Outcome results
None listed